ProTherax Ltd   Report issue

For profit Phase 2
Founded: East Morton United Kingdom (2011)

Organization Overview

First Clinical Trial
2019
NCT03865147
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ProTherax Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 7